136888-17-0 Usage
General Description
5-Chloro-1H-pyrrolo[2,3-b]pyridine is an organic compound counting among the heterocyclic aromatic compounds. It has the molecular formula C8H6ClN3 and typically appears as an off-white crystalline powder. Properties of this compound include a molecular weight of 183.61 g/mol, a boiling point of 330.8°C at 760 mmHg, and a flash point of 154.2°C. It has applications in chemical research, particularly where the synthesis of more complex compounds is required. Its handling and storage should involve protection from light and moisture due to its sensitivity to these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 136888-17-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,8,8 and 8 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 136888-17:
(8*1)+(7*3)+(6*6)+(5*8)+(4*8)+(3*8)+(2*1)+(1*7)=170
170 % 10 = 0
So 136888-17-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2O/c8-6-1-4-2-7(11)10-5(4)3-9-6/h1,3H,2H2,(H,10,11)
136888-17-0Relevant articles and documents
INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS
-
, (2020/05/15)
The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1.
Azaoxindole derivatives
-
, (2008/06/13)
This invention relates to novel 4-, 5-, 6-, and 7-azaoxindole derivatives. The compounds are anti-inflammatory and analgesic agents and inhibitors of one or more of prostaglandin H2 synthase, 5-lipoxygenase and interleukin-1 biosynthesis. They are useful in the treatment of chronic inflammatory diseases, allergy, psoriasis, various bone diseases, and immune dysfunctions such as systemic lupus erythematosis.
